Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Pieris Pharmaceuticals In...

    NASDAQ: PIRS · Real-Time Price · USD
    13.60
    -2.51 (-15.58%)
    At close: Dec 13, 2024, 9:00 PM
    -15.58%
    Bid 9.05
    Market Cap 17.96M
    Revenue (ttm) 1.35M
    Net Income (ttm) -15.95M
    EPS (ttm) -12.11
    PE Ratio (ttm) -1.1230388109000826
    Forward PE n/a
    Analyst n/a
    Ask 15
    Volume 51,728
    Avg. Volume (20D) 22,126
    Open 15.04
    Previous Close 16.11
    Day's Range 13.26 - 15.35
    52-Week Range 6.20 - 22.32
    Beta 0.66

    About PIRS

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol PIRS
    Website n/a
    Full Company Profile

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    9 months ago
    Pieris Pharmaceuticals shares are trading higher a... Unlock content with Pro Subscription
    news image

    5 months ago · businesswire.com

    PIERIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pieris Pharmaceuticals, Inc. - PIRS

    NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Pieris Pharmac...

    Add to Watchlist